Healthcare - Medical - Devices - NYSE - US
$ 10.01
3.2 %
$ 836 M
Market Cap
-16.15
P/E
CASH FLOW STATEMENT
-63.9 M
OPERATING CASH FLOW
-27 M
INVESTING CASH FLOW
129 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Paragon 28, Inc.
| Net Income | -47.8 M |
| Depreciation & Amortization | 15.5 M |
| Capital Expenditures | -28 M |
| Stock-Based Compensation | 12.4 M |
| Change in Working Capital | -53 M |
| Others | -13.9 M |
| Free Cash Flow | -91.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (47.8) | (67.3) | (13.7) | 3.5 | 3.1 |
| Depreciation & Amortization | 15.5 | 13.7 | 9.0 | 6.4 | 4.2 |
| Deferred Income Tax | 0 | (0.5) | 0.2 | 1.3 | (1.1) |
| Stock Based Compensation | 12.4 | 10.4 | 4.9 | 1.8 | 1.8 |
| Other Operating Activities | 9.0 | 3.1 | 5.1 | 8.9 | 2.6 |
| Change in Working Capital | (53.0) | (8.6) | (8.8) | (20.8) | 1.7 |
| Cash From Operations | (63.9) | (49.2) | (3.3) | 1.1 | 12.3 |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (28.0) | (43.1) | (21.3) | (10.8) | (18.0) |
| Other Items | 1.0 | (17.6) | (14.2) | 0.5 | 0.6 |
| Cash From Investing Activities | (27.0) | (60.7) | (35.5) | (10.3) | (17.5) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | (0.6) | (1.5) | (3.9) |
| Total Debt Repaid | 69.3 | 35.4 | 4.0 | (14.0) | 7.5 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.1) | 4.1 | (2.7) | 75.6 | 3.0 |
| Cash From Financing Activities | 128.7 | 39.5 | 131.1 | 24.0 | 6.5 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 37.2 | (70.9) | 91.9 | 14.9 | 1.4 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (91.9) | (92.3) | (24.6) | (9.7) | (5.7) |